CCA’s Barbara Herbert on implant treatment for opioid addiction

This week, the Food and Drug Administration is expected to decide if it will approve use of a treatment for opioid addiction that uses a system of implanted rods to release buprenorphine, a drug that has proven effective in addressing addiction. An article from NPR examines the pros and cons of the decision and quotes CCA’s Medical Director of Addiction Medicine, Dr. Barbara Herbert. While stating that “anything that might help people beat their opioid addiction is a good idea,” Barbara raises concerns about the cost of the treatment. She says that the high price could cause providers to turn away their patients who could benefit from the new approach.

Click here to read the full article.

Click here to hear Barbara Herbert discuss opioid addiction on our Dually Heard podcast.